Palvella Therapeutics PVLA
NASDAQ PVLA
$139.00 -0.83 (-0.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Operating Margin (2014 - 2024)

Updated

Palvella Therapeutics (PVLA) posted Operating Margin of -3318.87% for Q1 2024, down 2547.18 percentage points from -771.69% a year earlier and down 4349.35 percentage points from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Operating Margin (2014 - 2024) Analysis & Trends

For FY2023, Palvella Therapeutics' Operating Margin came in at -27.72%, up 140.12 percentage points from FY2022.

  • Annual Operating Margin shows a five-year change of +78.22 percentage points (FY2018 to FY2023).
  • In prior years, Palvella Therapeutics' Operating Margin was -167.84% in FY2022 (-2.87 pp), -164.97% in FY2021 (-49.29 pp), -115.68% in FY2020 (-57.00 pp) and -58.68% in FY2019 (+47.26 pp).
  • The Q1 2024 figure stands as the lowest quarterly Operating Margin in data going back to Q1 2015.
  • On a year-over-year basis, Operating Margin increased in five of the last eight quarters, with an average year-over-year change of -145.35 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q4 2023, with a gain of 1227.53 percentage points; the weakest was Q1 2024, with a drop of 2547.18 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was 1030.48% (Q4 2023), -60.49% (Q3 2023) and 10.27% (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Palvella Therapeutics 2.01 Bn 1.76 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -3,318.87%
Dec 31, 2023 1,030.48%
Sep 30, 2023 -60.49%
Jun 30, 2023 10.27%
Mar 31, 2023 -771.69%
Dec 31, 2022 -197.04%
Sep 30, 2022 -226.59%
Jun 30, 2022 -333.42%
Mar 31, 2022 -66.70%
Dec 31, 2021 -130.27%
Sep 30, 2021 -468.62%
Jun 30, 2021 -510.23%
Dec 31, 2020 -661.21%
Sep 30, 2020 -442.29%
Jun 30, 2020 -41.39%
Mar 31, 2020 -29.08%
Dec 31, 2019 -7.70%
Sep 30, 2019 -19.26%
Jun 30, 2019 -229.37%
Mar 31, 2019 -125.02%
API Access

Palvella Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PVLA&period=max&api_key=YOUR_API_KEY